DMRA: Damora Therapeutics, Inc.
Performance
DMRA -5.64%
Watchlist
Select an item
Summary
DMRA at a glance
DMRA returned -5.64% since Mar 10, 2026. Its worst drop since then was -44.13%, smaller than 31% of stocks on Redstone, and its Sharpe ratio of 0.20 beats 36% of stocks on Redstone. It hasn't paid a dividend since it listed.
Current Drawdown
-27.04%
Rolling Volatility
61.84%
Actions
Metrics
Risk Indicators*
Alpha-3.20%
Beta1.30x
Sharpe0.20
Sortino0.32
Omega1.04
Calmar-0.13
Martin0.77
Profile
About DMRA
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.5B
- Listed
- Oct 2020
- Employees
- 7
- Headquarters
- Waltham, MA
- Website
- damoratx.com
Comparisons